Finally, the identification of GATA2 and hsa-mir-27a-3p as agents capable of targeting ARG1, CD163, and HIF1A suggest that these two elements may function within the same pathway in both AIS and AMI. This evidence concerns the gene GATA2 and androgen insensitivity syndrome.